Jean-Marc Bellemin
Finanzdirektor/CFO bei IOVANCE BIOTHERAPEUTICS, INC.
Vermögen: 675 967 $ am 30.04.2024
Aktive Positionen von Jean-Marc Bellemin
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
IOVANCE BIOTHERAPEUTICS, INC. | Comptroller/Controller/Auditor | 11.03.2021 | - |
Finanzdirektor/CFO | 14.12.2020 | - | |
Treasurer | 14.12.2020 | - |
Karriereverlauf von Jean-Marc Bellemin
Ehemalige bekannte Positionen von Jean-Marc Bellemin
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
GRITSTONE BIO, INC. | Finanzdirektor/CFO | 01.01.2018 | 11.12.2020 |
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Corporate Officer/Principal | 01.01.2008 | 01.12.2017 |
Ausbildung von Jean-Marc Bellemin
Université Paris Dauphine-PSL | Undergraduate Degree |
Université Paris II Panthéon Assas | Graduate Degree |
ESSEC Business School | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 4 |
Frankreich | 4 |
Operativ
Director of Finance/CFO | 2 |
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
GRITSTONE BIO, INC. | Health Technology |
IOVANCE BIOTHERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Health Technology |
- Börse
- Insiders
- Jean-Marc Bellemin
- Erfahrung